Royal Bank of Canada’s Profound Medical PROF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.71M | Buy |
459,919
+23,922
| +5% | +$141K | ﹤0.01% | 2784 |
|
|
2025
Q1 | $2.54M | Buy |
435,997
+14,795
| +4% | +$86.1K | ﹤0.01% | 2499 |
|
|
2024
Q4 | $3.16M | Buy |
421,202
+19,877
| +5% | +$149K | ﹤0.01% | 2354 |
|
|
2024
Q3 | $3.19M | Buy |
401,325
+96
| +0% | +$764 | ﹤0.01% | 2335 |
|
|
2024
Q2 | $3.37M | Buy |
401,229
+1,103
| +0.3% | +$9.26K | ﹤0.01% | 2254 |
|
|
2024
Q1 | $3.41M | Sell |
400,126
-33
| -0% | -$281 | ﹤0.01% | 2219 |
|
|
2023
Q4 | $3.4M | Sell |
400,159
-1,674
| -0.4% | -$14.2K | ﹤0.01% | 2223 |
|
|
2023
Q3 | $4.1M | Buy |
401,833
+1,153
| +0.3% | +$11.8K | ﹤0.01% | 1947 |
|
|
2023
Q2 | $5.21M | Sell |
400,680
-314
| -0.1% | -$4.09K | ﹤0.01% | 1812 |
|
|
2023
Q1 | $3.73M | Buy |
400,994
+1,374
| +0.3% | +$12.8K | ﹤0.01% | 2053 |
|
|
2022
Q4 | $4.35M | Buy |
399,620
+13,000
| +3% | +$142K | ﹤0.01% | 1951 |
|
|
2022
Q3 | $1.56M | Sell |
386,620
-386
| -0.1% | -$1.56K | ﹤0.01% | 2664 |
|
|
2022
Q2 | $2.82M | Buy |
387,006
+65,305
| +20% | +$476K | ﹤0.01% | 2255 |
|
|
2022
Q1 | $2.9M | Buy |
321,701
+59,998
| +23% | +$540K | ﹤0.01% | 2369 |
|
|
2021
Q4 | $2.94M | Buy |
261,703
+8,927
| +4% | +$100K | ﹤0.01% | 2422 |
|
|
2021
Q3 | $3.7M | Buy |
252,776
+846
| +0.3% | +$12.4K | ﹤0.01% | 2214 |
|
|
2021
Q2 | $4.12M | Buy |
251,930
+245,850
| +4,044% | +$4.02M | ﹤0.01% | 2159 |
|
|
2021
Q1 | $122K | Sell |
6,080
-2,234
| -27% | -$44.8K | ﹤0.01% | 4844 |
|
|
2020
Q4 | $171K | Buy |
8,314
+2,453
| +42% | +$50.5K | ﹤0.01% | 4438 |
|
|
2020
Q3 | $103K | Buy |
5,861
+366
| +7% | +$6.43K | ﹤0.01% | 4488 |
|
|
2020
Q2 | $93K | Buy |
5,495
+1,141
| +26% | +$19.3K | ﹤0.01% | 4434 |
|
|
2020
Q1 | $43K | Buy |
4,354
+654
| +18% | +$6.46K | ﹤0.01% | 4735 |
|
|
2019
Q4 | $40K | Buy |
+3,700
| New | +$40K | ﹤0.01% | 4951 |
|